Founded in December 2012, Junshi Biosciences is an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapeutics. (Image courtesy of JunshiPharma)) SHANGHAI, Sept. 24, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization […]
The post Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab first appeared on San Francisco News.
—-
Author : SanFrancisco
Publish date : 2024-09-25 10:49:14
Copyright for syndicated content belongs to the linked Source.